BioPharma Credit (BPCR) Competitors GBX 0.88 +0.00 (+0.23%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock BPCR vs. ATST, ABDN, 3IN, PHLL, JGGI, RCP, BUR, BPT, MNKS, and EMGShould you be buying BioPharma Credit stock or one of its competitors? The main competitors of BioPharma Credit include Alliance Trust (ATST), abrdn (ABDN), 3i Infrastructure (3IN), Petershill Partners (PHLL), JPMorgan Global Growth & Income (JGGI), RIT Capital Partners (RCP), Burford Capital (BUR), Bridgepoint Group (BPT), Monks (MNKS), and Man Group (EMG). These companies are all part of the "asset management" industry. BioPharma Credit vs. Its Competitors Alliance Trust abrdn 3i Infrastructure Petershill Partners JPMorgan Global Growth & Income RIT Capital Partners Burford Capital Bridgepoint Group Monks Man Group Alliance Trust (LON:ATST) and BioPharma Credit (LON:BPCR) are both financial services companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment. Which has preferable valuation and earnings, ATST or BPCR? BioPharma Credit has higher revenue and earnings than Alliance Trust. Alliance Trust is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlliance Trust£652.76M0.00£601.66M£2.12N/ABioPharma Credit£12.99B0.08£10.42B£0.0910.00 Do insiders and institutionals believe in ATST or BPCR? 6.9% of Alliance Trust shares are held by institutional investors. Comparatively, 41.5% of BioPharma Credit shares are held by institutional investors. 2.4% of Alliance Trust shares are held by insiders. Comparatively, 6.2% of BioPharma Credit shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor ATST or BPCR? In the previous week, Alliance Trust's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score. Company Overall Sentiment Alliance Trust Neutral BioPharma Credit Neutral Which has more risk and volatility, ATST or BPCR? Alliance Trust has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, BioPharma Credit has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Is ATST or BPCR more profitable? Alliance Trust has a net margin of 92.17% compared to BioPharma Credit's net margin of 80.20%. Alliance Trust's return on equity of 17.93% beat BioPharma Credit's return on equity.Company Net Margins Return on Equity Return on Assets Alliance Trust92.17% 17.93% 10.95% BioPharma Credit 80.20%8.51%4.98% Is ATST or BPCR a better dividend stock? Alliance Trust pays an annual dividend of GBX 26 per share. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 795.5%. Alliance Trust pays out 1,226.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BioPharma Credit pays out 7,957.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SummaryAlliance Trust beats BioPharma Credit on 7 of the 12 factors compared between the two stocks. Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BPCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPCR vs. The Competition Export to ExcelMetricBioPharma CreditAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£1.04B£1.25B£6.45B£2.96BDividend Yield13.43%4.36%4.17%5.02%P/E Ratio10.0021.8313.52147.82Price / Sales0.082,404.951,783.52258,971.92Price / Cash1.1960.8148.9127.97Price / Book0.011.213.175.28Net Income£10.42B£264.68M£1.25B£5.90B7 Day PerformanceN/A0.46%0.57%1.00%1 Month PerformanceN/A2.81%3.29%5.03%1 Year Performance3.04%6.63%15.41%80.88% BioPharma Credit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPCRBioPharma CreditN/AGBX 0.88+0.2%N/A+2.8%£1.04B£12.99B10.00N/AATSTAlliance TrustN/AN/AN/AN/A£3.58B£652.76M600.003ABDNabrdn0.9174 of 5 starsGBX 186.80-0.1%GBX 172-7.9%+20.8%£3.34B£1.49B10.624,7193IN3i InfrastructureN/AGBX 333.74-1.6%N/A+4.5%£3.08B£374M878.27N/ANews CoveragePHLLPetershill Partners2.3048 of 5 starsGBX 226.50+2.5%GBX 240+6.0%+11.9%£3.08B£706.00M9.19N/ANews CoverageGap UpJGGIJPMorgan Global Growth & IncomeN/AGBX 549+0.2%N/A-4.8%£2.83B£660.56M4.52N/ANews CoverageRCPRIT Capital PartnersN/AGBX 1,940.50-1.3%N/A+3.5%£2.80B£103.46M16.7762BURBurford Capital3.0703 of 5 starsGBX 949.50-0.6%GBX 1,600+68.5%-0.1%£2.61B£299.55M16.99140News CoverageBPTBridgepoint Group2.1418 of 5 starsGBX 312.46-1.5%GBX 359.33+15.0%+31.7%£2.58B£272.35M56.76391News CoverageAnalyst ForecastMNKSMonksN/AGBX 1,298flatN/A+11.4%£2.50B£610.03M4.21N/ATrending NewsEarnings ReportEMGMan Group2.3263 of 5 starsGBX 172.90+0.3%GBX 278+60.8%-29.5%£2.50B£1.69B8.161,790News Coverage Related Companies and Tools Related Companies Alliance Trust Alternatives abrdn Alternatives 3i Infrastructure Alternatives Petershill Partners Alternatives JPMorgan Global Growth & Income Alternatives RIT Capital Partners Alternatives Burford Capital Alternatives Bridgepoint Group Alternatives Monks Alternatives Man Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BPCR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
